Bioceramics Market Growth Trajectory Through 2024-2033

Spread the love

The Bioceramics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Bioceramics Market:

https://www.thebusinessresearchcompany.com/report/bioceramics-global-market-report

According to The Business Research Company’s Bioceramics Global Market Report 2024, The bioceramics market size has grown strongly in recent years. It will grow from $3.87 billion in 2023 to $4.14 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increasing aging population, growing incidence of chronic diseases, demand for aesthetic dentistry, regulatory approvals and standards, increased focus on regenerative medicine..

The bioceramics market size is expected to see strong growth in the next few years. It will grow to $5.37 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rising demand for bioactive ceramics, expanding applications in neurology, growing awareness of dental health, international collaborations in medical research, focus on personalized medicine.. Major trends in the forecast period include emergence of advanced 3d printing techniques, development of multifunctional bioceramic materials, utilization of nanotechnology in bioceramic design, introduction of antibacterial bioceramics, focus on bioresorbable bioceramics for temporary implants, advancements in bioceramic coatings for implants..

The growing prevalence of orthopedic and dental disorders is expected to propel the growth of the bioceramics market going forward. Orthopedic and dental disorders represent two distinct categories of medical conditions. Orthopedic disorders primarily concern the musculoskeletal system, whereas dental disorders primarily impact oral health and the structures found within the mouth. Bioceramics find extensive applications in both orthopedics and dentistry because of their biocompatible nature, resilience, and capacity to closely resemble the characteristics of natural bones and teeth. In orthopedics, they are frequently employed for implantation, such as in hip and knee joint replacements. Similarly, in dentistry, bioceramics are widely utilized for various dental restorations like crowns, bridges, and dental implants. For instance, in March 2021, according to Lancashire County Council, a UK-based upper-tier local authority, there were an estimated 470,000 workers affected by work-related musculoskeletal disorders between 2020 and 2021. Furthermore, in November 2022, according to the World Health Organization, a Switzerland-based intergovernmental organization, 3.55 billion individuals worldwide suffer from oral disorders, and global cases of oral diseases have increased by 1 billion from previous years. Therefore, the growing prevalence of orthopedic and dental disorders will drive the growth of the bioceramics market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=13387&type=smp

The bioceramics market covered in this report is segmented –

1) By Type: Bioinert, Bioactive, Bioresorbable

2) By Material: Aluminum Oxide, Zirconia, Calcium Phosphate, Other Materials

3) By Application: Orthopedic, Dental Implants, Biomedical, Other Applications

Major companies operating in the bioceramics market are introducing new advanced materials, such as LithaBone HA 480, to improve the performance of bioceramic implants and the quality and performance of 3D-printed bone implants. LithaBone HA 480 is a type of hydroxyapatite (HA), which is the main mineral component of bone. It is designed to be used in the production of patient-specific ceramic implants with extremely improved wall thicknesses and, therefore, more geometric flexibility. For instance, in December 2022, Lithoz GmbH, an Austria-based biomaterial company, launched LithaBone HA 480, a bone substitute material for ceramic 3D printing. The material is designed to be biocompatible, durable, and osteoconductive, making it ideal for use in medical applications such as bone grafts, dental implants, and orthopedic prostheses. It has the potential to revolutionize the way that bone implants are manufactured, making them more effective, affordable, and accessible to patients.

The bioceramics market report table of contents includes: